Recommendations for Addressing Harm-Benefit Analysis and Implementation in Ethical Evaluation - Report from the AALAS-FELASA Working Group on Harm-Benefit Analysis - Part 2

被引:49
作者
Laber, Kathy [1 ]
Newcomer, Christian E. [2 ]
Decelle, Thierry [3 ]
Everitt, Jeffrey I. [4 ]
Guillen, Javier [5 ]
Bronstad, Aurora [6 ]
机构
[1] NIEHS, Comparat Med Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA
[2] AAALAC Int, Frederick, MD USA
[3] Sanofi, Marcy Letoile, France
[4] GlaxoSmithKline, Dept Lab Anim Sci, Res Triangle Pk, NC USA
[5] AAALAC Int, Pamplona, Spain
[6] Univ Bergen, Dept Clin Med, Bergen, Norway
关键词
harm-benefit; ethical review; ANIMALS; RISK;
D O I
10.1177/0023677216642397
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
International regulations and guidelines strongly suggest that the use of animal models in scientific research should be initiated only after the authority responsible for the review of animal studies has concluded a well-thought-out harm-benefit analysis (HBA) and deemed the project to be appropriate. The AALAS-FELASA working group on HBA has performed a literature review and based on this review, proposed a method for HBA. Examples of the working group's approach are included in this report.
引用
收藏
页码:21 / 42
页数:22
相关论文
共 33 条
[1]  
AALAS-FELASA working group on harm-benefit analysis, 2015, CURR CONC HARM BEN 1
[2]  
[Anonymous], ESF EMRC POSITION PR
[3]  
BATESON P, 1992, NEW SCI, V134, P30
[4]  
BATESON P, 1986, NEW SCI, V109, P30
[5]  
Bernard C., 1865, An Introduction to the Study of Experimental Medicine
[6]   Evaluating the ethical acceptability of animal research [J].
Bout, Henriette J. ;
van Vlissingen, J. Martje Fentener ;
Karssing, Edgar D. .
LAB ANIMAL, 2014, 43 (11) :411-414
[7]  
Boyd CM, 2012, AHRQ PUBLICATION
[8]  
CAMPBELL WR, 1963, CAN MED ASSOC J, V89, P127
[9]  
CIOMS-ICLAS, 2012, International Guiding Principles For Biomedical Research Involving Animals
[10]  
Dandie G., 2012, ANZCCART NEWS, V25, P3